Date | EBITDA Margin | EBIT Margin | Depreciation and Amortization | EBIT |
---|
CEO | Mr. Kevin R. Thornal |
IPO Date | Nov. 6, 2014 |
Location | United States |
Headquarters | 1800 Bridge Parkway |
Employees | 1,215 |
Sector | Healthcare |
Industries |
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
Past 5 years
USD 13.01
USD 18.20
USD 156.08
USD 13.61
USD 2.73
USD 34.07
USD 15.46
USD 71.21
USD 49.95
USD 59.35
USD 33.88
USD 138.24
USD 24.05
USD 33.70
USD 5.84
StockViz Staff
February 4, 2025
Any question? Send us an email